SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Laurus Labs informs about change in name of wholly owned subsidiary company

04 Jul 2020 Evaluate

Laurus Labs has informed that in furtherance to disclosure dated July 01, 2020 regarding the completion of acquisition of 100% shares of Phekolong Pharmaceuticals, the Company further updated that the name of Phekolong Pharmaceuticals Pty. Ltd., the Wholly Owned Subsidiary of the Company has been changed to Laurus Generics SA (Pty) Ltd, with effect from July 02, 2020.

The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

1169.00 2.50 (0.21%)
05-May-2026 10:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.00
Dr. Reddys Lab 1280.25
Cipla 1321.00
Zydus Lifesciences 904.65
Lupin 2343.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×